🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Daniel T. DeArmond

The University of Texas at San Antonio Health Science Center

ORCID: 0000-0002-7255-3750
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Single-Cell Proteomic Profiling Identifies Combined AXL and JAK1 Inhibition as a Novel Therapeutic Strategy for Lung Cancer”.

Single-Cell Proteomic Profiling Identifies Combined AXL and JAK1 Inhibition as a Novel Therapeutic Strategy for Lung Cancer

Cancer Research(2020)10.1158/0008-5472.can-19-3183
N/A
0DataRank · unranked
62 citations

Chia-Nung Hung, Daniel T. DeArmond, Meizhen Chen, Chun-Lin Lin, Paweł A. Osmulski +19 more

AXL-initiated paracrine activation of pSTAT3 enhances mesenchymal and vasculogenic supportive features of tumor-associated macrophages

Cell Reports(2023)10.1016/j.celrep.2023.113067
N/A
0DataRank · unranked
22 citations

Meizhen Chen, Daniel T. DeArmond, Cheryl Hsiang-Ling Chiu, Catherine A. Limboy, Xi Tan +19 more

Ex Vivo Drug Testing of Patient-Derived Lung Organoids to Predict Treatment Responses for Personalized Medicine

Preprints.org(2023)10.20944/preprints202306.1176.v1
N/A
0DataRank · unranked
0 citations

M. K. Williams, Ryan A. Williams, Meizhen Chen, Samaneh Kamali, Vaishnavi Sambandam +12 more

Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicine

Lung Cancer(2024)10.1016/j.lungcan.2024.107533
N/A
0DataRank · unranked
22 citations

Chia‐Nung Hung, Madison Williams, Ryan A. Williams, Meizhen Chen, Samaneh Kamali +14 more